Becker's Healthcare April 3, 2024
Paige Twenter

The FDA has authorized the nation’s first AI-powered sepsis detection tool, artificial intelligence company Prenosis said April 3.

Clinicians have long been searching for — and testing — detection tools for sepsis, a life-threatening condition that at least 1.7 million adults in the U.S. develop each year. One in three patients who die in hospitals had sepsis during their stay, according to the CDC.

The authorized device is Sepsis Immunoscore, a machine learning software that integrates with hospital EHRs, according to a Prenosis news release. It uses 22 parameters to evaluate a patient’s biological status, calculate a sepsis risk score and four discrete risk categories, and display the results. The tool is not an alert system.

Many...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Provider, Technology
FDA warns GLP-1 compounder over safety rules
GLP-1 drug approvals: A breakdown
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Certainty vs. speed: How do patients feel about the tradeoff for new cancer drugs?

Share This Article